HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.

Abstract
This study examines 45 cases of trisomy 13 and 59 cases of trisomy 18 and reports an algorithm to identify pregnancies with a fetus affected by trisomy 13 or 18 by a combination of maternal age fetal nuchal translucency (NT) thickness, and maternal serum free beta-hCG and PAPP-A at 11-14 weeks of gestation. In this mixed trisomy group the median MoM NT was increased at 2.819, whilst the median MoMs for free beta-hCG and PAPP-A were reduced at 0.375 and 0.201 respectively. We predict that with the use of the combined trisomy 13 and 18 algorithm and a risk cut-off of 1 in 150 will for a 0.3% false positive rate allow 95% of these chromosomal defects to be identified at 11-14 weeks. Such algorithms will enhance existing first trimester screening algorithms for trisomy 21.
AuthorsKevin Spencer, Kypros H Nicolaides
JournalPrenatal diagnosis (Prenat Diagn) Vol. 22 Issue 10 Pg. 877-9 (Oct 2002) ISSN: 0197-3851 [Print] England
PMID12378569 (Publication Type: Journal Article)
CopyrightCopyright 2002 John Wiley & Sons, Ltd.
Chemical References
  • Chorionic Gonadotropin, beta Subunit, Human
  • Pregnancy-Associated Plasma Protein-A
Topics
  • Algorithms
  • Chorionic Gonadotropin, beta Subunit, Human (blood)
  • Chromosomes, Human, Pair 13
  • Chromosomes, Human, Pair 18
  • False Positive Reactions
  • Female
  • Humans
  • Maternal Age
  • Neck (diagnostic imaging, embryology)
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy-Associated Plasma Protein-A (analysis)
  • Risk Factors
  • Trisomy
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: